Immunology/Autoimmune
- Ref-No. Technology
-
01-00988
INSPECT - Intron encoded reporter transcripts for minimally invasive monitoring of coding and non-coding RNAs
-
01-01045
Ex vivo method for determination of oxidative stress and diagnosis of ferroptosis-associated diseases
-
02-00374
Phytosphingosine Derivatives as Adjuvants in Immune Stimulation
-
03-00397
Plasma cell-specific antibodies targeting BCMA for the treatment of multiple myeloma and autoimmune diseases
-
03-00481
Spacer-nick genome editing of hematopoietic stem and progenitor cells and T cells
-
03-00539
Sleeping Beauty transposase variants with increased safety due to reduced half-life
-
10-00128
Functionalized Nanoparticles for Viral Clearance
-
14-00142
Flow cytometric basophil activation test for automated, high-throughput allergy diagnostics
-
14-00173
Replacement of allergen challenge: Safely scoring prevalence & severity of allergies
-
15-00461a
The physiological breast-milk proteins S100A8 and S100A9 promote an eubiotic gut state in infants
-
15-00461b
Novel treatment for sepsis in newborns
-
15-00538
Genetically Manipulated Cornea for Transplantation
-
15-00611
Engineered Immune Cells to Specifically Eliminate Undesired Immune Responses
-
15-00740
Maintenance of regulatory T cell phenotype by expression of IL-2 fusion protein
-
15-00750
The ASGPR-CAR – a liver-specific chimeric antigen receptor
-
15-00785
Novel CARs for the Treatment of Multiple Sclerosis and Alzheimer´s Disease
-
15-00795
Novel CARs for the Treatment of Inflammatory Bowel Disease
- 22-00009 Quiescent B Cells for immune suppression in gene therapy
- 22-00017 Functional IFN-gamma memory in CD4+ T cells: Method for improved T cell therapy and disease monitoring in autoimmune diseases
- 22-00020 Bispecific antibodies for cell-type-specific TNF inhibition
-
23-00069
NMDAR targeted CAAR-T cell therapy
-
32-00083
Immunosuppressant resistance in anti-viral T cell products
-
32-00124
CD3-CAR NK-92 cell-mediated TCR+ depletion
-
32-00128
Method for Assessing Out-of-Specification (OOS) CAR T-Cell Products and Predicting Patient Response
-
32-00187
HSV signature antibodies predict the development of anti-NMDA receptor encephalitis
-
32-00192
Base editing enzymes for multiplex editing with simultaneous gene knock-in and knock-out
-
32-00200
Gene editing of the proteinase 3 autoantigen as a novel treatment for ANCA-associated vasculitis
-
32-00202
An engineered serine integrase for targeted gene transfer in human cells
-
32-00222
Method for direct measurement of functional avidity of T cells
-
33-00002
Rapid, simultaneous and non-destructive blood diagnostics using a multi-omics NMR platform
-
43-00013
CRISPR StAR: facilitating high resolution genetic screening in complex in vivo models
